<i>N</i>-Methyl-<i>N</i>-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1<i>H</i>-indol-2-yl)methyl)prop-2-yn-1-amine, a New Cholinesterase and Monoamine Oxidase Dual Inhibitor

Óscar M. Bautista‐Aguilera, Abdelouahid Samadi, Mourad Chioua, Katarina Nikolić, Slavica Filipić, Danica Agbaba, Elena Soriano, Lucía de Andrés, Marı́a Isabel Rodrı́guez-Franco, Stefano Alcaro,

Journal of Medicinal Chemistry · 2014 · 65 citations · 35 references

DOIFull text

Open access

Concepts

Abstract

On the basis of N-((5-(3-(1-benzylpiperidin-4-yl)propoxy)-1-methyl-1H-indol-2-yl)methyl)-N-methylprop-2-yn-1-amine (II, ASS234) and QSAR predictions, in this work we have designed, synthesized, and evaluated a number of new indole derivatives from which we have identified N-methyl-N-((1-methyl-5-(3-(1-(2-methylbenzyl)piperidin-4-yl)propoxy)-1H-indol-2-yl)methyl)prop-2-yn-1-amine (2, MBA236) as a new cholinesterase and monoamine oxidase dual inhibitor.

References

35